SEC Form 4 · accession 0001225208-18-016433
CLOROX CO /DE/ · CLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Denise Garner
Officer — SVP - Chief Innovation Officer
Period of report
Dec 6, 2018
Accepted (ET)
Dec 10, 2018 · 6:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000021076
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 6, 2018 | M | 6,293 | $84.45 | A | 16,241 | D | |
| Common Stock | Dec 6, 2018 | M | 5,322 | $72.11 | A | 21,563 | D | |
| Common StockF1 | Dec 6, 2018 | S | 11,615 | $164.0028 | D | 9,948 | D | |
| Common Stock | Dec 7, 2018 | M | 7,080 | $89.82 | A | 17,028 | D | |
| Common Stock | Dec 7, 2018 | M | 437 | $84.45 | A | 17,465 | D | |
| Common Stock | Dec 7, 2018 | M | 378 | $72.11 | A | 17,843 | D | |
| Common StockF2 | Dec 7, 2018 | S | 6,751 | $162.7227 | D | 11,092 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $72.11 | Dec 6, 2018 | M | 5,322 | D | Sep 11, 2013 | Sep 11, 2022 | Common Stock | 5,322 | 378 | D |
| Stock Option (Right to Buy) | $84.45 | Dec 6, 2018 | M | 6,293 | D | Sep 17, 2014 | Sep 17, 2023 | Common Stock | 6,293 | 437 | D |
| Stock Option (Right to Buy) | $72.11 | Dec 7, 2018 | M | 378 | D | Sep 11, 2013 | Sep 11, 2022 | Common Stock | 378 | 0 | D |
| Stock Option (Right to Buy) | $84.45 | Dec 7, 2018 | M | 437 | D | Sep 17, 2014 | Sep 17, 2023 | Common Stock | 437 | 0 | D |
| Stock Option (Right to Buy) | $89.82 | Dec 7, 2018 | M | 7,080 | D | Sep 17, 2015 | Sep 17, 2024 | Common Stock | 7,080 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $164.00 to $164.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $162.45 to $164.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.